Galedra
Sign in Sign up

Checked, not settled

Checks out so far.

“In the phase 1 mRNA-1215 trial, antibody responses increased after the booster dose and remained elevated for at least one year.”

2 of 4 review checks done · 1 counted · 1 by the author only

Supported · 0.8808 under ledger-default@0.3.0 at snapshot 27745 · review checks 1 of 4 · provisional until audited. The number is model-conditional, not a share of truth.

Share:

Or just the link: https://galedra.org/claims/0b3df062-5667-8b4f-8b8a-9122bcfadece/card

See the evidence ·